|
1 The Medication Assistant |
|
|
1 | (7) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
4 | (1) |
|
Certification and Registry Requirements |
|
|
4 | (1) |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
Responsibilites and Practice Limits |
|
|
5 | (1) |
|
|
6 | (2) |
|
|
8 | (5) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
9 | (1) |
|
The Five Rights of Delegation |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
11 | (1) |
|
|
12 | (1) |
|
|
13 | (10) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
14 | (1) |
|
|
14 | (1) |
|
Durable Power of Attorney |
|
|
14 | (1) |
|
|
14 | (1) |
|
Physician Orders for Life-Sustaining Treatment |
|
|
14 | (1) |
|
|
14 | (2) |
|
Federal Food, Drug, and Cosmetic Act of 1938 |
|
|
16 | (1) |
|
Comprehensive Drug Abuse Prevention-and Control Act of 1970 |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
19 | (2) |
|
|
21 | (1) |
|
|
21 | (2) |
|
4 Assisting With the Nursing Process |
|
|
23 | (21) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
24 | (2) |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (1) |
|
Assisting With Assessment |
|
|
27 | (1) |
|
|
27 | (9) |
|
Measuring Weight and Height |
|
|
36 | (2) |
|
|
38 | (3) |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
42 | (2) |
|
5 Body Structure and Function |
|
|
44 | (15) |
|
Cells, Tissues, and Organs |
|
|
44 | (1) |
|
|
45 | (1) |
|
The Musculoskeletal System |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
The Central Nervous System |
|
|
48 | (1) |
|
The Peripheral Nervous System |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
The Male Reproductive System |
|
|
54 | (1) |
|
The Female Reproductive System |
|
|
54 | (1) |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
|
57 | (2) |
|
|
59 | (19) |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
60 | (1) |
|
Healthcare-Associated Infection |
|
|
60 | (1) |
|
Multidrug-Resistant Organisms |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (2) |
|
|
63 | (1) |
|
|
63 | (1) |
|
Transmission-Based Precautions |
|
|
63 | (4) |
|
Personal Protective Equipment (PPE) |
|
|
67 | (1) |
|
|
67 | (3) |
|
|
70 | (1) |
|
Masks and Respiratory Protection |
|
|
71 | (1) |
|
|
72 | (1) |
|
The Bloodborne Pathogen Standard |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
72 | (1) |
|
Engineering and Work Practice Controls |
|
|
72 | (1) |
|
Personal Protective Equipment (PPE) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
Stopping the Spread of Infection |
|
|
73 | (1) |
|
|
74 | (2) |
|
|
76 | (2) |
|
|
78 | (6) |
|
|
79 | (1) |
|
Example of Generic and Brand Names for Drugs |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
79 | (1) |
|
Routes of Drug Administration |
|
|
79 | (1) |
|
|
80 | (1) |
|
|
80 | (1) |
|
|
80 | (1) |
|
|
80 | (1) |
|
|
80 | (1) |
|
Factors Influencing Drug Action |
|
|
81 | (1) |
|
|
82 | (1) |
|
|
82 | (1) |
|
|
82 | (2) |
|
8 Life Span Considerations |
|
|
84 | (6) |
|
|
84 | (1) |
|
Drugs Applied to the Skin |
|
|
84 | (1) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (1) |
|
Therapeutic Drug Monitoring |
|
|
86 | (1) |
|
Assisting with the Nursing Process |
|
|
86 | (2) |
|
|
88 | (2) |
|
9 Drug Orders and Prescriptions |
|
|
90 | (14) |
|
|
92 | (1) |
|
|
92 | (1) |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
93 | (2) |
|
|
95 | (1) |
|
|
95 | (1) |
|
The Medication Administration Record |
|
|
96 | (4) |
|
|
100 | (1) |
|
|
100 | (2) |
|
Assisting With Transcription |
|
|
102 | (1) |
|
|
102 | (2) |
|
|
104 | (12) |
|
Drug Distribution Systems |
|
|
104 | (1) |
|
Floor or Ward Stock System |
|
|
104 | (1) |
|
Individual Prescription Order System |
|
|
105 | (1) |
|
|
105 | (1) |
|
Computer-Controlled Dispensing System |
|
|
106 | (1) |
|
Bar Code Medication Administration (BCMA) |
|
|
106 | (1) |
|
|
107 | (1) |
|
|
108 | (1) |
|
Assisted Living Residences |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
111 | (1) |
|
The Self-administration of Drugs |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
113 | (3) |
|
11 Oral, Sublingual, and Buccal Drugs |
|
|
116 | (9) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
119 | (3) |
|
Sublingual and Buccal Drugs |
|
|
122 | (1) |
|
|
123 | (2) |
|
|
125 | (7) |
|
|
125 | (1) |
|
Applying Creams, Lotions, Ointments, and Powders |
|
|
126 | (2) |
|
Applying Nitroglycerin Ointment |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
130 | (2) |
|
13 Eye, Ear, Nose, and Inhaled Drugs |
|
|
132 | (10) |
|
|
132 | (2) |
|
|
134 | (2) |
|
|
136 | (2) |
|
|
138 | (2) |
|
|
140 | (2) |
|
14 Vaginal and Rectal Drugs |
|
|
142 | (6) |
|
|
142 | (3) |
|
|
145 | (2) |
|
|
147 | (1) |
|
15 Drugs Affecting the Nervous System |
|
|
148 | (15) |
|
Drugs Affecting the Autonomic Nervous System |
|
|
149 | (1) |
|
Drug Class: Adrenergic Agents |
|
|
149 | (2) |
|
Drug Class: Alpha- and Beta-Adrenergic Blocking Agents |
|
|
151 | (1) |
|
Drug Class: Cholinergic Agents |
|
|
151 | (1) |
|
Drug Class: Anticholinergic Agents |
|
|
152 | (1) |
|
|
153 | (1) |
|
|
154 | (1) |
|
Drug Class: Benzodiazepines |
|
|
154 | (1) |
|
Drug Class: Nonbarbiturate, Nonbenzodiazepine Sedative-Hypnotic Agents |
|
|
155 | (1) |
|
Drugs Used for Parkinson's Disease |
|
|
155 | (2) |
|
Drug Class: Dopamine Agonists |
|
|
157 | (1) |
|
Amantadine Hydrochloride (Gocovri and OsmolexER) |
|
|
157 | (1) |
|
Carbidopa, Levodopa (Sinemet and Rytary) |
|
|
157 | (1) |
|
Pramipexole (Mirapex and Mirapex ER) |
|
|
158 | (1) |
|
Ropinirole (Requip and Requip XL) |
|
|
158 | (1) |
|
|
158 | (1) |
|
Drug Class: COMT Inhibitor |
|
|
159 | (1) |
|
Entacapone (Comtan and Stalevo) |
|
|
159 | (1) |
|
Drug Class: Anticholinergic Agents |
|
|
159 | (1) |
|
Drug Class: Monoamine Oxidase Type B Inhibitor |
|
|
160 | (1) |
|
Drugs Used for Alzheimer's Disease |
|
|
160 | (1) |
|
Drug Class: Acetylcholinesterase Inhibitors |
|
|
161 | (1) |
|
|
161 | (1) |
|
Drug Class: NMDA Receptor Inhibitors |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
16 Drugs Used for Mental Health Disorders |
|
|
163 | (14) |
|
Drugs Used for Anxiety Disorders |
|
|
163 | (1) |
|
Drug Class: Benzodiazepines |
|
|
164 | (2) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
Drugs Used for Mood Disorders |
|
|
166 | (1) |
|
Drug Class: Monoamine Oxidase Inhibitors |
|
|
167 | (2) |
|
Drug Class: Selective Serotonin Reuptake Inhibitors |
|
|
169 | (1) |
|
Drug Class: Serotonin-Norepinephrine Reuptake Inhibitors |
|
|
169 | (1) |
|
Drug Class: Tricyclic Antidepressants |
|
|
169 | (1) |
|
|
170 | (1) |
|
Bupropion Hydrochloride (Wellbutrin) |
|
|
170 | (1) |
|
|
170 | (1) |
|
Trazodone Hydrochloride (Desyrel) |
|
|
170 | (1) |
|
|
171 | (1) |
|
Vortioxetine (Trintellix) |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
171 | (1) |
|
Drug Class: Antipsychotic Agents |
|
|
172 | (2) |
|
Drugs Used for Alcohol Rehabilitation |
|
|
174 | (1) |
|
|
174 | (1) |
|
|
174 | (1) |
|
|
175 | (1) |
|
|
175 | (2) |
|
17 Drugs Used for Seizure Disorders |
|
|
177 | (8) |
|
|
178 | (1) |
|
Drug Class: Benzodiazepines |
|
|
178 | (1) |
|
|
179 | (1) |
|
|
179 | (1) |
|
Other Antiepileptic drugs |
|
|
179 | (1) |
|
|
179 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
181 | (1) |
|
Oxcarbazepine (Trileptal) |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
182 | (1) |
|
|
182 | (1) |
|
|
182 | (1) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (2) |
|
18 Drugs Used to Manage Pain |
|
|
185 | (11) |
|
|
187 | (1) |
|
Addiction and Drug Tolerance |
|
|
188 | (1) |
|
Drug Class: Opiate Agonists |
|
|
188 | (2) |
|
Drug Class: Opiate Partial Agonists |
|
|
190 | (1) |
|
Drug Class: Opiate Antagonists |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
191 | (1) |
|
Drug Class: Prostaglandin Inhibitors |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
192 | (1) |
|
Drug Class: Non-Steroidal Anti-Inflammatory Drugs |
|
|
192 | (2) |
|
|
194 | (1) |
|
|
194 | (2) |
|
19 Drugs Used to Lower Lipids |
|
|
196 | (5) |
|
Drug Therapy for Hyperlipidemia |
|
|
196 | (1) |
|
Drug Class: Bile Acid-Binding Resins |
|
|
197 | (1) |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
Omega-3 Fatty Acids (Lovaza) |
|
|
199 | (1) |
|
|
199 | (2) |
|
20 Drugs Used to Treat Hypertension |
|
|
201 | (10) |
|
Drug Therapy for Hypertension |
|
|
202 | (1) |
|
|
202 | (1) |
|
Drug Class: Beta-Adrenergic Blocking Agents |
|
|
203 | (1) |
|
Drug Class: Angiotensin-Converting Enzyme Inhibitors |
|
|
203 | (1) |
|
Drug Class: Angiotensin II Receptor Blockers |
|
|
204 | (1) |
|
Drug Class: Direct Renin Inhibitor |
|
|
204 | (1) |
|
Drug Class: Aldosterone Receptor Blocking Agent |
|
|
205 | (1) |
|
Drug Class: Calcium Channel Blockers |
|
|
206 | (1) |
|
Drug Class: Alpha-1 Adrenergic Blocking Agents |
|
|
207 | (1) |
|
Drug Class: Central-Acting Alpha-2 Agonists |
|
|
207 | (1) |
|
Drug Class: Direct Vasodilators |
|
|
208 | (1) |
|
|
208 | (1) |
|
|
209 | (2) |
|
21 Drugs Used to Treat Dysrhythmias |
|
|
211 | (4) |
|
Drug Therapy for Dysrhythmias |
|
|
211 | (1) |
|
Drug Class: Class I Antidysrhythmic Agents |
|
|
211 | (1) |
|
|
211 | (1) |
|
Flecainide Acetate (Tambocor) |
|
|
212 | (1) |
|
|
212 | (1) |
|
Drug Class: Class II Antidysrhythmic Agents |
|
|
212 | (1) |
|
Drug Class: Class III Antidysrhythmic Agents |
|
|
212 | (1) |
|
Amiodarone Hydrochloride (Pacerone) |
|
|
213 | (1) |
|
|
213 | (1) |
|
Drug Class: Class IV Antidysrhythmic Agents |
|
|
213 | (1) |
|
Drug Class: Miscellaneous Antidysrhythmic Agents |
|
|
213 | (1) |
|
|
213 | (1) |
|
|
214 | (1) |
|
22 Drugs Used to Treat Angina, Peripheral Vascular Disease, and Heart Failure |
|
|
215 | (10) |
|
|
215 | (1) |
|
|
216 | (1) |
|
Drug Class: Beta-Adrenergic Blocking Agents |
|
|
217 | (1) |
|
Drug Class: Calcium Channel Blockers |
|
|
218 | (1) |
|
Drug Class: Angiotensin-Converting Enzyme Inhibitors |
|
|
218 | (1) |
|
Drug Class: Myocardial Cell Sodium Channel Blocker |
|
|
219 | (1) |
|
Drug Therapy for Peripheral Vascular Disease |
|
|
219 | (1) |
|
Drug Class: Hemorrheologic Agent |
|
|
220 | (1) |
|
Drug Class: Platelet Aggregation Inhibitor |
|
|
220 | (1) |
|
Drug Therapy for Heart Failure |
|
|
221 | (1) |
|
Drug Class: Digitalis Glycosides |
|
|
221 | (1) |
|
Drug Class: Angiotensin-Converting Enzyme Inhibitors |
|
|
222 | (1) |
|
Drug Class: Angiotensin II Receptor Blockers |
|
|
222 | (1) |
|
Drug Class: Beta-Adrenergic Blocking Agents |
|
|
222 | (1) |
|
Drug Class: Miscellaneous Agent |
|
|
222 | (1) |
|
|
223 | (2) |
|
23 Drugs Used for Diuresis |
|
|
225 | (5) |
|
|
225 | (1) |
|
Drug Class: Loop Diuretics |
|
|
225 | (1) |
|
Drug Class: Thiazide Diuretics |
|
|
226 | (1) |
|
Drug Class: Potassium-Sparing Diuretics |
|
|
227 | (1) |
|
Spironolactone (Aldactone) |
|
|
228 | (1) |
|
|
228 | (1) |
|
Drug Class: Combination Diuretic Products |
|
|
228 | (1) |
|
|
229 | (1) |
|
24 Drugs Used to Treat Thromboembolic Diseases |
|
|
230 | (6) |
|
Drug Therapy for Thromboembolic Diseases |
|
|
230 | (1) |
|
Drug Class: Platelet Inhibitors |
|
|
231 | (1) |
|
|
231 | (2) |
|
|
233 | (1) |
|
|
233 | (1) |
|
|
233 | (1) |
|
Drug Class: Factor Xa Inhibitors |
|
|
233 | (1) |
|
Drug Class: Anticoagulants |
|
|
233 | (1) |
|
|
233 | (1) |
|
Drug Class: Thrombin Inhibitors |
|
|
234 | (1) |
|
|
235 | (1) |
|
25 Drugs Used to Treat Respiratory Diseases |
|
|
236 | (12) |
|
Drug Therapy for Upper Respiratory Diseases |
|
|
237 | (1) |
|
Drug Class: Sympathomimetic Decongestants |
|
|
237 | (2) |
|
Drug Class: Antihistamines |
|
|
239 | (1) |
|
Drug Class: Respiratory Antiinflammatory Agents |
|
|
239 | (1) |
|
Intranasal Corticosteroids |
|
|
239 | (2) |
|
Cromolyn Sodium (Nasalcrom) |
|
|
241 | (1) |
|
Drug Therapy for Lower Respiratory Diseases |
|
|
241 | (1) |
|
|
242 | (1) |
|
|
242 | (1) |
|
Drug Class: Beta-Adrenergic Bronchodilating Agents |
|
|
243 | (1) |
|
Drug Class: Anticholinergic Bronchodilating Agents |
|
|
244 | (1) |
|
Drug Class: Respiratory Antiinflammatory Agents |
|
|
244 | (1) |
|
Drug Class: Antileukotriene Agents |
|
|
244 | (1) |
|
Drug Class: Phosphodiesterase-4 Inhibitor (PDE-4) |
|
|
244 | (2) |
|
|
246 | (2) |
|
26 Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Diseases |
|
|
248 | (6) |
|
Drug Therapy for Gastroesophogeal Reflux Disease and Peptic Ulcer Diseases |
|
|
248 | (1) |
|
|
248 | (2) |
|
Drug Class: Histamine (H2)-Receptor Antagonists |
|
|
250 | (1) |
|
Drug Class: Gastrointestinal Prostaglandins |
|
|
250 | (1) |
|
Drug Class: Proton Pump Inhibitors |
|
|
250 | (1) |
|
Drug Class: Coating Agents |
|
|
251 | (1) |
|
Drug Class: Prokinetic Agents |
|
|
251 | (1) |
|
|
252 | (2) |
|
27 Drugs Used to Treat Nausea, Vomiting, Constipation, and Diarrhea |
|
|
254 | (8) |
|
Drug Therapy for Nausea and Vomiting |
|
|
256 | (1) |
|
Drug Class: Dopamine Antagonists |
|
|
256 | (1) |
|
Drug Class: Serotonin Antagonists |
|
|
256 | (1) |
|
Drug Class: Anticholinergic Agents |
|
|
256 | (2) |
|
Drug Class: Corticosteroids |
|
|
258 | (1) |
|
Drug Class: Benzodiazepines |
|
|
259 | (1) |
|
|
259 | (1) |
|
Drug Class: Neurokinin-1 Receptor Inhibitor |
|
|
259 | (1) |
|
Drug Therapy for Constipation and Diarrhea |
|
|
259 | (1) |
|
|
259 | (1) |
|
Drug Class: Antidiarrheal Agents |
|
|
260 | (1) |
|
|
261 | (1) |
|
28 Drugs Used to Treat Diabetes and Thyroid Diseases |
|
|
262 | (10) |
|
Drug Therapy for Diabetes |
|
|
262 | (1) |
|
|
262 | (2) |
|
Drug Class: Biguanide Oral Antidiabetic Agents |
|
|
264 | (1) |
|
Drug Class: Sulfonylurea Oral Hypoglycemic Agents |
|
|
265 | (1) |
|
Drug Class: Meglitinide Oral Hypoglycemic Agents |
|
|
266 | (1) |
|
Drug Class: Thiazolidinedione Oral Antidiabetic Agents |
|
|
266 | (1) |
|
Drug Class: Alpha-Glucosidase Inhibitor Agents |
|
|
267 | (1) |
|
Drug Class: Sodium-Glucose Cotransporter 2 Inhibitors |
|
|
267 | (1) |
|
Drug Class: Dipeptidyl Peptidase-4 Inhibitors |
|
|
267 | (1) |
|
Drug Therapy for Thyroid Diseases |
|
|
268 | (1) |
|
Drug Class: Thyroid Replacement Hormones |
|
|
268 | (1) |
|
Drug Class: Antithyroid Drugs |
|
|
268 | (2) |
|
|
270 | (2) |
|
29 Corticosteroids and Gonadal Hormones |
|
|
272 | (7) |
|
|
272 | (1) |
|
Drug Class: Mineralocorticoids |
|
|
272 | (1) |
|
Drug Class: Glucocorticoids |
|
|
273 | (1) |
|
The Gonads and Gonadal Hormones |
|
|
274 | (1) |
|
|
274 | (1) |
|
|
274 | (2) |
|
|
276 | (1) |
|
|
277 | (2) |
|
30 Drugs Used in Men's and Women's Health |
|
|
279 | (9) |
|
Drug Therapy for Leukorrhea And Genital Infections |
|
|
279 | (1) |
|
Drugs Used for Contraception |
|
|
279 | (1) |
|
Drug Class: Oral Contraceptives |
|
|
279 | (3) |
|
Drug Class: Transdermal Contraceptive |
|
|
282 | (1) |
|
|
283 | (1) |
|
Drug Therapy for Osteoporosis |
|
|
283 | (1) |
|
Drug Class: Biphosphonates |
|
|
283 | (1) |
|
Drug Therapy for Benign Prostatic Hyperplasia |
|
|
284 | (1) |
|
Drug Class: Alpha-1 Adrenergic Blocking Agents |
|
|
284 | (1) |
|
Drug Class: Antiandrogen Agents |
|
|
285 | (1) |
|
Drug Therapy for Erectile Dysfunction |
|
|
285 | (1) |
|
Drug Class: Phosphodiesterase Inhibitors |
|
|
285 | (1) |
|
|
286 | (2) |
|
31 Drugs Used to Treat Urinary System Disorders |
|
|
288 | (5) |
|
Drug Therapy for Urinary Tract Infections |
|
|
288 | (1) |
|
Drug Class: Fosfomycin Antibiotics |
|
|
288 | (1) |
|
Drug Class: Urinary Antibacterial Agents |
|
|
289 | (1) |
|
Drug Therapy for Overactive Bladder |
|
|
289 | (1) |
|
Drug Class: Anticholinergic Drugs |
|
|
290 | (1) |
|
Drug Class: Beta-3 Adrenergic Agonists |
|
|
290 | (1) |
|
Miscellaneous Urinary Agents |
|
|
291 | (1) |
|
Bethanechol Chloride (Urecholine) |
|
|
291 | (1) |
|
Phenazopyridine Hydrochloride (Pyridium) |
|
|
291 | (1) |
|
|
291 | (2) |
|
32 Drugs Used to Treat Eye Disorders |
|
|
293 | (9) |
|
Drug Therapy for Glaucoma |
|
|
293 | (1) |
|
Drug Class: Carbonic Anhydrase Inhibitors |
|
|
293 | (1) |
|
Drug Class: Cholinergic Agents |
|
|
294 | (1) |
|
Drug Class: Alpha-Adrenergic Agents |
|
|
294 | (2) |
|
Drug Class: Beta-Adrenergic Blocking Agents |
|
|
296 | (1) |
|
Drug Class: Prostaglandin Agonists |
|
|
297 | (1) |
|
|
297 | (1) |
|
Drug Class: Anticholinergic Agents |
|
|
297 | (1) |
|
Drug Class: Antifungal Agents |
|
|
298 | (1) |
|
Drug Class: Antiviral Agents |
|
|
299 | (1) |
|
Drug Class: Ophthalmic Antibiotics |
|
|
299 | (1) |
|
Drug Class: Corticosteroids |
|
|
299 | (1) |
|
Drug Class: Ophthalmic Antiinflammatory Agents |
|
|
299 | (1) |
|
Drug Class: Antihistamines |
|
|
300 | (1) |
|
Drug Class: Antiallergenic Agents |
|
|
300 | (1) |
|
Drug Class: Artificial Tear Solutions |
|
|
300 | (1) |
|
|
300 | (2) |
|
33 Drugs Used in the Treatment of Cancer |
|
|
302 | (5) |
|
|
304 | (2) |
|
|
306 | (1) |
|
34 Drugs Affecting Muscles and Joints |
|
|
307 | (5) |
|
Drug Therapy for Muscle Spasms |
|
|
307 | (1) |
|
Drug Class: Centrally Acting Skeletal Muscle Relaxants |
|
|
307 | (1) |
|
Drug Class: Direct-Acting Skeletal Muscle Relaxant |
|
|
308 | (1) |
|
|
309 | (1) |
|
|
309 | (1) |
|
|
309 | (1) |
|
|
310 | (1) |
|
|
310 | (1) |
|
|
310 | (1) |
|
|
310 | (2) |
|
35 Drugs Used to Treat Infections |
|
|
312 | (16) |
|
|
312 | (1) |
|
|
313 | (2) |
|
Drug Class: Aminoglycosides |
|
|
315 | (1) |
|
Drug Class: Cephalosporins |
|
|
315 | (1) |
|
|
315 | (1) |
|
|
316 | (1) |
|
|
317 | (1) |
|
|
318 | (1) |
|
Drug Class: Tetracyclines |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
320 | (1) |
|
|
320 | (1) |
|
|
320 | (1) |
|
|
320 | (1) |
|
|
321 | (1) |
|
|
321 | (1) |
|
|
321 | (1) |
|
Topical Antifungal Agents |
|
|
321 | (2) |
|
Systemic Antifungal Agents |
|
|
323 | (1) |
|
|
323 | (1) |
|
|
323 | (1) |
|
|
324 | (1) |
|
|
324 | (1) |
|
|
324 | (1) |
|
|
324 | (1) |
|
|
325 | (1) |
|
|
325 | (1) |
|
|
325 | (1) |
|
|
325 | (1) |
|
Ribavirin (Rebetol and Ribasphere) |
|
|
326 | (1) |
|
|
326 | (2) |
|
36 Nutrition and Herbal and Dietary Supplement Therapy |
|
|
328 | (10) |
|
|
328 | (1) |
|
|
329 | (1) |
|
|
329 | (1) |
|
Nutrients and Macronutrients |
|
|
329 | (1) |
|
|
330 | (4) |
|
Herbal and Dietary Supplements |
|
|
334 | (2) |
|
|
336 | (2) |
Appendix A A Review of Arithmetic |
|
338 | (11) |
Glossary |
|
349 | (5) |
Key Abbreviations |
|
354 | (2) |
Index |
|
356 | |